In eye diseases, there is only limited evidence about VEGFR2 involvement in the pathogenetic role of uPAR with indirect demonstrations that the interaction of uPAR with VEGFR2 may promote VEGF-induced angiogenesis in in vitro and in vivo models of neovessel formation [77]. Here, VEGFA is linked to eye disorder.